Advertisement

2013 Fall Clinical Lipid Update Highlights

Keynote: HDL Review

Remaley

Alan T. Remaley, MD, PhD

Alan T. Remaley, MD, PhD presented HDL Review: Translating new findings on LCAT into novel therapies. He explains the biology of HDL and LCAT, and he discusses Phase I Clinical trial of rLCAT and single patient IND treatment.

Start Presentation Slides Audio Only

Tags:


Is Raising HDL Dead or Not?

John R. Guyton, M.D.

John R. Guyton, M.D. presented Niacin's Triple Paradox and Thoughts on HDL. Dr. Guyton discusses the three paradox of Niacin.

Start Presentation Slides Audio Only

Tags:


Genetics of Familial Hypercholesterolemia

Cuchel

Marina Cuchel, MD, PhD

Marina Cuchel, MD, PhD presented Genetics of Familial Hypercholesterolemia. Dr. Cuchel discuss FH (Familial Hypercholesterolemia), the underlying genetic defects that cause FH, and how the molecular basis of FH affects lipid lowering treatment.

Start Presentation Slides Audio Only

Tags:


Genetic Testing – Where are we? Nuts & Bolts of Testing

Knowles

Josh W. Knowles, MD, PhD

Josh W. Knowles, MD, PhD presented Nuts and Bolts of Genetic Testing for Familial Hypercholesterolemia. Dr. Knowles discusses the importance of genetic testing, the cost effectiveness of cascade screening, and what to expect when ordering genetic testing for patients

Start Presentation Slides Audio Only

Tags:


Cardiometabolic Consequences of Sitting Time

Marc Hamilton, PhD

Marc Hamilton, PhD presented Cardiometabolic Consequences of Sitting Time: Inactivity Physiology. Dr. Hamilton explains inactivity physiology and Low-Intensity Physical Activity, LIPA.

Start Presentation Slides Audio Only

Tags:


Copyright © 2018 National Lipid Association. All Rights Reserved.

Privacy Policy Terms of Service